Pediatricians' group urges that all infants get new RSV shot
All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation's leading pediatrics group said.
Aug 16, 2023
0
32
Amino Acids, Peptides, and Proteins: News and Research on Antibodies, Monoclonal
MeSH tree: D12.776.124.486.485.114.224
Study finds most infants receiving ICU-level care for RSV had no underlying medical condition
Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network ...
Aug 15, 2023
0
49
Study shows immunotherapy may benefit a subset of patients with penile cancer
Penile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typically begin with platinum chemotherapy. Immune checkpoint inhibitors (ICIs) are novel therapies ...
Aug 11, 2023
0
42
A select group: Study may bring improved therapy to preselected lung cancer patients
Nonsmokers who develop lung cancer can be treated effectively with new drugs, but their tumors refuse to surrender without a fight. The drugs stop working in the long term because the tumors acquire secondary mutations that ...
Aug 9, 2023
0
55
Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy, study finds
Breast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likelihood of patients experiencing cardiovascular side effects, like cardiotoxicity, are not well-known ...
Aug 2, 2023
1
39
RSV is everywhere right now. What parents need to know about respiratory syncytial virus
This winter, we're having to get our heads around another respiratory virus—RSV.
Jul 26, 2023
0
34
Belly fat hinders digestive disease medications
The mass and composition of our bodies can significantly affect the way medications are metabolized and absorbed. Investigators at Cedars-Sinai have found that inflammatory bowel disease (IBD) patients with higher levels ...
Jul 25, 2023
0
45
Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?
Trial results of a new drug to treat Alzheimer's disease, donanemab, shows it can slow cognitive decline by 35%. The drug has been hailed as a "turning point" in Alzheimer's treatment.
Jul 19, 2023
0
55
FDA approves new drug to protect against RSV in infants
Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.
Jul 18, 2023
0
83
Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers
Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and urelemab, an anti-CD137 agonist ...
Jul 17, 2023
0
71
